Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
Recruiting
Observational Study
Pediatric Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this study is to utilize all donated pediatric tumor tissues and cells obtained from autopsy to prospectively develop novel patient derived orthotopic xenograft (PDOX) mouse models as well as in vitro cell culture model systems for pediatric cancers, and also provide tissue samples to other researchers and organizations (eg, CBTN, DIPG Registry, COG).
Trial Locations
Loading…
Loading trial locations…
| Facility |
City |
State |
Country |
Status |
Eligibility Criteria
Inclusion Criteria:
* Pediatric patients with cancer and non-cancer tumor types (solid, liquid, neuro-oncology)
* Signed consent for post mortem tissue donation and autopsy
Exclusion Criteria:
* Signed consent for post mortem tissue donation and autopsy not obtained
Inclusion Criteria:
* Pediatric patients with cancer and non-cancer tumor types (solid, liquid, neuro-oncology)
* Signed consent for post mortem tissue donation and autopsy
Exclusion Criteria:
* Signed consent for post mortem tissue donation and autopsy not obtained